Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab

INTRODUCTION: Patients with systemic lupus erythematosus (SLE) with B-lymphocyte stimulator (BLyS) levels ≥ 2 ng/mL are at increased risk of flare. A regression analysis was undertaken to identify routine clinical measures that correlate with BLyS ≥ 2 ng/mL. Efficacy and safety of belimumab 10 mg/kg...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, D A, Thompson, A, Tang, Y, Hammer, A E, Molta, C T, Gordon, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785993/
https://www.ncbi.nlm.nih.gov/pubmed/26385220
http://dx.doi.org/10.1177/0961203315604909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785993/
https://www.ncbi.nlm.nih.gov/pubmed/26385220
http://dx.doi.org/10.1177/0961203315604909

Ejemplares similares